The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative
review - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Cachexia has been recognized for a long time as an adverse effect of cancer. It is
associated with reduced physical function, reduced tolerance to anticancer therapy, and …

Cancer is a life-threatening disease that has plagued humans for centuries. The vast
majority of cancer-related mortality results from metastasis. Indeed, the invasive growth of …

Background Cancer cachexia worsens the treatment outcomes of patients with small-cell
lung cancer (SCLC). However, no reliable biomarker of cancer cachexia is yet known …

Cancer cachexia is a metabolic syndrome that can be present even in the absence of weight
loss ('precachexia'). Cachexia is often compounded by pre-existing muscle loss, and is …

Purpose Cancer cachexia (CC) is commonly seen in advanced lung cancer patients and
associated with poor prognosis. However, little is known about CC that develops during …

More Is Better: A Multimodality Approach to Cancer Cachexia | The Oncologist | Oxford
Academic Skip to Main Content Advertisement Oxford Academic Journals Books Search …

Simple Summary Immunotherapy has revolutionized the therapeutic options for patients
living with non-small-cell lung cancer (NSCLC). Despite the unprecedented results achieved …

Key Points Cancer cachexia appears to be underrecognized and undertreated by oncology
HCPs in a multinational study. Cancer cachexia is a poor prognostic indicator that can …

Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life,
responsiveness to chemotherapy, and survival in advanced cancer patients. Our …